SASergei A. Andreichenko

Sergei A. Andreichenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sergei A. Andreichenko has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Tatiana Valerievna Klypa

    Federal Research Clinical Center of the Federal Medical-Biological Agency

    9 shared publications
  • Mikhail V. Bychinin

    Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA of Russia, 115682 Moscow, Russia

    7 shared publications
  • Irina Arkadievna Mandel

    Sechenov First Moscow State Medical University (Sechenov University)

    4 shared publications
  • Андрейченко Сергей Александрович

    Центральная клиническая больница «РЖД-Медицина»; Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства России

    4 shared publications
  • Nadezhda A. Kolyshkina

    Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency

    3 shared publications
  • Alexander V. Troitskiy

    Intensive Care Unit, Federal Scientific and Clinical Center of Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency of Russia, Moscow, Russia

    2 shared publications

Latest Publications

  • Open Access

    Prognostic Index for Compensation of Reduced Heart and Lung Functions in Patients with Sepsis

    by S. A. Andreychenko, D. O. Ovcharov, K. V. Yatskov, G. N. Arbolishvili, M. A. Rakhmanov, T. V. Klypa

    Magnitude of heart rate (HR) fluctuation during sepsis and septic shock can significantly impact tissue perfusion and organ dysfunction. The aim of the study is to examine and compare the predictive characteristics of a composite index based on clinical parameters and demographic variables for early risk stratification of mortality in patients with sepsis. Materials and Methods. In a multicenter retrospective cohort study, data from 257 patients with sepsis or septic shock were analyzed, including age, sex, height, weight, severity of illness, comorbidities, bedside hemodynamic and respiratory monitoring parameters upon admission to the ICU, and 3 hours after the initiation of intensive therapy, as well as treatment outcomes. Statistical characteristics of the generated Prognostic Index for Compensation of Reduced Cardiorespiratory Function (PICRCF) were assessed, calculated as the ratio of the product obtained by multiplying heart rate by respiratory rate and by age to the product obtained by multiplying of diastolic blood pressure by body surface area (BSA). To identify clinical and laboratory predictors of fatal outcomes, all patients were divided into two groups: survivors and those who died during treatment. Results. The hospital mortality rate in the analyzed patient sample was 48%. Differences were found between those who died and those who survived in terms of age, scores on the Glasgow (RR), heart rate (HR), and blood pressure (BP), as well as PICRCF values both upon admission ((PICRCF 0) and after 3 hours of intensive care ((PICRCF 3). Notably, (PICRCF 3 demonstrated the highest discriminative performance among all studied predictors (AUC 0.800; 95% CI 0.744–0.855) with a cutoff value of 1.1 (sensitivity 69%, specificity 85%). In the Cox proportional hazards model, (PICRCF 3 was the only independent predictor of mortality (OR 1.313 (95% CI 1.062–1.623), p = 0.012). Additionally, PICRCF values were associated with the number of days without organ replacement support. Conclusion. The indicators reflecting the state of the cardiovascular and respiratory systems, indexed according to anthropometric and age characteristics, have several advantages over standard prognostic scales in the early risk stratification of patients with sepsis. The simplicity, accessibility, and rapid measuring of the components for calculating PICRCF allow for dynamic assessment of the patient's condition from the first minutes of admission to the ICU.

  • Comparative assessment of baseline values of biomarker combinations in early prediction of mortality in patients with sepsis

    by S. A. Andreychenko, D. O. Ovcharov, K. V. Yatskov, G. N. Arbolishvili, M. A. Rakhmanov, T. V. Klypa

    Introduction. Early detection of patients with a high risk of death in sepsis makes it possible to optimize intensive care. The objective of the study was to perform a comparative assessment of the prognostic values of various laboratory indicators and their combinations in predicting mortality in patients with sepsis. Materials and methods. We analyzed the medical records of 280 patients diagnosed with sepsis. Levels of more than 50 laboratory parameters were assessed upon admission in groups of patients who survived and those who died during treatment. The discriminatory abilities of the identified laboratory predictors were assessed using ROC analysis. The Kaplan–Meier method was used to assess survival. Results. Among the studied patients, the mortality rate was 50%. Differences between the groups of surviving and deceased patients were identified according to levels of urea, total protein, albumin, lactate, pH, platelet and neutrophil count. The lowest level α (p < 0.001) was found for the ratio of urea to creatinine and lactate to albumin. Based on this, an integral biomarker consisting of the product of these two parameters was calculated and analyzed. Its values also differed between groups and amounted to 3.9 (2.9–6.8) and 9.8 (4.8–18.8) in the group of surviving and deceased patients, respectively (p < 0.001). When performing ROC analysis, the optimal cut-off point for our predictor, separating survivors from deceased patients, was 6.6 with an AUC of 0.758 (95% CI 0.693–0.813), with a sensitivity of 67% and specificity of 75%, exceeding similar indicators for the APACHE II scale. We also found that patients with low levels of our proposed predictor had a threefold increase in median survival compared to the subgroup of patients with high levels (23 days and 8 days, respectively; p < 0.001). Conclusion. An integrated indicator based on plasma levels of urea, creatinine, lactate, and albumin is a simple and accessible biomarker for early prediction of mortality in patients with sepsis.


  • Open Access

    Difficulties in the Treatment of Complications and Rehabilitation after COVID-19. A Clinical Case

    by S. A. Andreichenko, M. A. Slepukhina, M. V. Bychinin, T. V. Klypa, M. A. Atamanova, V. G. Shirinsky, G. E. Karapetyan

    The severe course of the new coronavirus infection (COVID-19) is associated with multiple life-threatening complications that lead to delayed initiation of active rehabilitation and unfavorable long-term treatment outcomes. Tracheoesophageal fistula is one of these complications. The specific feature of this event in COVID-19 is delayed tissue regeneration which requires a non-standard approach to management of such patients.The article presents a clinical case of a pregnant patient after a complicated severe course of COVID-19 with the development of tracheoesophageal fistula, sepsis, and weakness syndrome acquired in ICU. The combination of complications of the disease led to a prolonged (about five months) period of rehabilitation.Modern standard components of intensive therapy of such patients including regular monitoring of endotracheal/tracheostomy tube cuff pressure, dynamic assessment of nutritional status and its correction, rational antimicrobial therapy, screening of psychiatric disorders and early rehabilitation, will minimize the number of both early and delayed complications of COVID-19.

  • Open Access

    The effectiveness of dexmedetomidine in patients with severe COVID-19

    by Sergey A. Andreychenko, Mikhail V. Bychinin, Irina A. Mandel’, Tatiana V. Klypa, Андрейченко Сергей Александрович

    Background: Mortality in patients with severe COVID-19 remains high. Finding therapies that can improve the outcome in these patients is an urgent task. Aims: To evaluate the clinical efficacy of dexmedetomidine in the complex treatment of patients with a severe course of COVID-19. Methods: The retrospective study included 50 adult patients with severe COVID-19 admitted to the intensive care unit (ICU). The primary outcome of the study was the incidence of delirium. The secondary results of the study were the dynamics of gas exchange indicators (PaO2 and PaCO2) and inflammatory markers (C-reactive protein, CRP; procalcitonin, lymphocyte count, and neutrophil-lymphocyte ratio, NLR) on day 3 and day 5 of the treatment, as well as the duration of mechanical ventilation (MV), length of stay (LOS) in the ICU and in the hospital and mortality. Results: The incidence of delirium did not differ between the dexmedetomidine group and the control group (41 and 48%, respectively; p=0.661). The LOS in the ICU and in the hospital, as well as the MV duration, was comparable between the groups. However, the hospital mortality in the dexmedetomidine treatment group was lower than that in the control group (10.3% and 42.9%, respectively; p=0.008). The addition of dexmedetomidine to the therapy complex did not affect the blood gas composition but contributed to the increase in the number of lymphocytes (p=0.006) and to the NLS decrease (p=0.002) by the fifth day of treatment. At the same time, no significant changes in the CRP and procalcitonin levels were observed. Conclusion: In the treatment group, the mortality was statistically significantly lower than it was in the control group. At the same time, the use of dexmedetomidine did not reduce the incidence of delirium, the length of stay in the ICU and in the hospital, and the duration of mechanical ventilation in patients with severe COVID-19. The revealed relationship between the use of dexmedetomidine and NLR and the number of lymphocytes suggests an immune-mediated effect on the outcome in this category of patients. Prospective randomized trials are needed to confirm the beneficial effects of dexmedetomidine on the immune system and mortality.


  • Low Circulating Vitamin D in Intensive Care Unit–Admitted COVID-19 Patients as a Predictor of Negative Outcomes

    by Mikhail V Bychinin, Tatiana V Klypa, Irina A Mandel, Sergey A Andreichenko, Vladimir P Baklaushev, Gaukhar M Yusubalieva, Nadezhda A Kolyshkina, Aleksandr V Troitsky

    Vitamin D deficiency has been associated with an increased risk of respiratory infections. The study aimed to evaluate the serum 25-hydroxyvitamin D [25(OH)D] concentration in patients admitted to the intensive care unit (ICU) as a predictor of coronavirus disease 2019 (COVID-19) mortality. A single-center retrospective observational study was conducted. Forty adult patients (50% men) with confirmed COVID-19 who were admitted to the ICU were enrolled. The primary endpoint was mortality at day 60. Serum 25(OH)D concentration was measured on the day of admission to the ICU. We used the Mann-Whitney test, Fisher's exact test, Kaplan-Meier analysis, and receiver operator characteristic (ROC) analysis to assess serum 25(OH)D concentration as a predictor of COVID-19 mortality. All 40 patients had a low median (IQR) serum 25(OH)D concentration at admission [12 (9-15) ng/mL]. The median (IQR) serum 25(OH)D concentration was greater in survivors [13.3 (10.0-17.1) ng/mL, n = 22] than in nonsurvivors [9.6 (7.9-14.2) ng/mL; n = 18], P = 0.044. The area under the ROC curve was 0.69 (95% CI: 0.52, 0.86; P = 0.044). The 60-d mortality rate of those with serum 25(OH)D concentrations ≤9.9 ng/mL (n = 14, 71%) tended to be greater than that of those with concentrations >9.9 ng/mL (n = 26, 31%) (P = 0.065), and they had a 5.6-fold higher risk of death (OR: 5.63; 95% CI: 1.35, 23.45; P = 0.018). The ICU patients had a low serum 25(OH)D concentration. Serum 25(OH)D concentrations ≤9.9 ng/mL on admission can be used to predict in-hospital mortality in patients with COVID-19.This trial was registered at clinicaltrials.gov as NCT04450017.


  • Open Access

    ICU Acquired Weakness in patients with respiratory failure

    by Sergei A. Andreichenko, Mikhail V. Bychinin, Dmitriy I. Korshunov, Tatiana V. Klypa, Андрейченко Сергей Александрович

    Background:Most patients with severe respiratory failure in intensive care unit (ICU) require bed rest. The limitation of physical activity leads to some adverse consequences such as ICU Acquired Weakness (ICUAW). Progression of respiratory failure, including that caused by the new coronavirus infection (COVID-19), can lead to the development of acute respiratory distress syndrome, the treatment of which contributes to a combination of risk factors for the development of ICUAW. Traditional diagnostic methods have certain limitations. Muscle ultrasonography is a modern tool for early detection of muscle mass loss.Aims:To compare different methods of early ICUAW screening and to estimate the incidence and peculiarities of ICUAW in patients with respiratory failure of infectious genesis.Methods:31 patients with severe coronavirus pneumonia (COVID-19+) and 13 patients with viral and/or bacterial lung infection (COVID-19 -) were included in the study. The muscle mass loss percent from day 1 to day 7 was higher in the COVID-19 - group (p=0.022). These patients also had longer durations of the ICU and hospital stay but a significantly lower mortality (2.5 times).Results:The analysis of the parameters of deceased and living patients regardless of the lung damage etiology showed a correlation between the indices of hand grip strength dynamometry (handgrip test) and ultrasonography of the thigh muscles: F1 and D1 (rho=0.6, p=0.003), F1 and S1 (rho=0.6, p=0.005), D1 and F7 (rho=0.9, p=0.001). In addition, the examined levels of the ICUAW markers were associated with age - F1 (rho=-0.6, p=0.001), D1 (rho=-0.4, p=0.003), S1 (rho=-0.4, p=0.004).Conclusions:During the critical illness, ICUAW develops by the 3d day of bed rest in two thirds of patients with respiratory failure of different infectious genesis. The correlation between the investigated markers of ICUAW and age indicates that elderly patients are the most vulnerable category in respect to the formation and progression of muscle weakness in the ICU. The handgrip test can serve as a reliable and simple method of ICUAW screening. Early identification of patients with ICUAW should provide the improvement of nutritional support and individualization of rehabilitation.


  • Open Access

    Prevalence of hypovitaminosis D in COVID-19 patients in the intensive care unit

    by Mikhail V. Bychinin, Irina A. Mandel’, Tatiana V. Klypa, Nadezhda A. Kolyshkina, Sergei A. Andreichenko, Андрейченко Сергей Александрович

    Background: The prevalence of hypovitaminosis D has not been studied in the Russian Federation for the group of patients with severe and extremely severe COVID-19 in the intensive care unit (ICU). Aims: To study the prevalence of hypovitaminosis D in patients with COVID-19 treated in the ICU and to determine the relationship between the vitamin D status and disease outcome. Methods: The retrospective study included 103 adult patients with severe and extremely severe COVID-19 hospitalized in the ICU. Results: 94% patients (n = 97) showed a significant decrease in the concentration of 25 (OH) D in their blood serum 11 ng/ml [7; 15 ng/ml]. 37% (n = 38) of patients showed vitamin D deficiency, 46% (n = 47) had severe vitamin D deficiency, 12% (n = 12) had vitamin D insufficiency, 5% (n = 6) had normal vitamin D levels. In the group of patients with vitamin D levels less than 10 ng/ml, the mortality rate was significantly higher than that in the group of patients with the levels of vitamin D exceeding 10 ng/ml (66% and 42%, p = 0.018). These two groups of patients also significantly differed in their age (p = 0.018), history of diabetes mellitus (p = 0.059), white blood cell count (p = 0.045), neutrophil to lymphocyte ratio (p = 0.017), D-dimer level (p = 0.05) and troponin T level (p = 0.054). Conclusion: A high incidence of vitamin D insufficiency in patients with COVID-19 treated in the ICU has been identified. Severe vitamin D deficiency was more often found in elderly patients with diabetes mellitus, and was associated with the increased mortality. The identified relationship of the vitamin D deficiency with the neutrophilic-lymphocytic index suggests an immuno-mediated effect on the outcome of patients with COVID-19.


  • Open Access

    Clinical characteristics of patients admitted to an ICU with COVID-19. Predictors of the severe disease

    by Tatiana V. Klypa, Mikhail V. Bychinin, Irina A. Mandel, Sergey A. Andreichenko, Andrey I. Minets, Nadezhda A. Kolyshkina, Aleksandr V. Troitsky, Андрейченко Сергей Александрович, Минец Андрей Иванович

    Background. Providing an efficient care to the patients of the most severely affected category ICU patients has become one of the serious problems appearing in the COVID-19 pandemics. A typical patients clinical portrait in ICUs of COVID centers is very similar in different countries, however, the key to improve the treatment results for critically ill patients has not yet been found. Currently, 160 patients have been treated in the ICU of the FRCC of the FMBA of Russia. To May 16, 2020, the lethality in the ICU was 48.9% by the closed cases, the lethality among the patients on ventilation was 57.9%. The aim of the study is to identify predictors of the severe pneumonia caused by the SARS-CoV-2 virus, and to describe the clinical characteristics of patients admitted to an intensive care unit of the COVID-center of the Federal Research Clinical Center of FMBA of Russia. Methods. In this report, we describe the clinical, laboratory and instrumental data of 70 patients admitted to the ICU, and discuss the found predictors of the severe COVID-19 pneumonia course. Results. The following factors have been determined which contribute to the development of the severe course of the disease and to the risk of the unfavorable outcome: male gender, age older than 70.5 years, initial lymphocytopenia of lower than 0.98109/l, neutrophil to lymphocyte ratio of higher than 7.75, D-dimer level of higher than 0.85 g/ml, IL-6 of higher than 184.7 pg/ml, procalcitonin of higher than 0.22 ng/ml, hyperglycemia of higher than 9 mmol/l, signs of myocardial damage (high-sensitive troponin Т of higher than 22 pg/ml, echocardiography data), signs of the presence of a secondary bacterial infection and a severe vitamin D deficiency (lower than 9.9 ng/ml). The pathophysiological basics for the contribution of each factor to the severe course of the disease are provided. Conclusions. Clinical features of the patients change in course of pandemia. These influenced by changes in treatment approaches and new discoveries in disease pathophysiology. Above mentioned predictors of severe course of disease is partly modifiable and we are able to influence them and perhaps achieve better results in treatment of severe patients with COVID-19


  • Open Access

    Assessment and identification of predictors of performance of early rehabilitation of patients in the general intensive care unit. Article

    by Sergey A. Andreychenko, M. V. Bychinin, T. V. Klypa

    S.A. Andreychenko, M.V. Bychinin, T.V. Klypa Introduction. Currently, there are no universal criteria for assessing the volume of predicted functional recovery of patients during rehabilitation in intensive care units. Objective. To identify independent predictors of efficiency of rehabilitation of patients after a critical illness. Materials and methods. The study was conducted on the basis of a general ICU in 2017–2019. Patients with a short course of rehabilitation (≤ 7 days), deep impairment of consciousness (≤ 7 points on the Glasgow coma scale), decompensated multiple organ failure were excluded from the study. Clinical and laboratory data of 82 patients were retrospectively analyzed, including baseline severity of the condition, degree of functional independence and mobility, assessment of neurological deficit, incidence of depression and delirium, duration of mechanical ventilation and terms of hospitalization. We used a calculated indicator to analyze the effectiveness of rehabilitation — the rehabilitation potential index (RPI). Patients were assigned to the group of effective rehabilitation (ER) or ineffective rehabilitation (IR) depending on the level of RPI. Results. The duration of mechanical ventilation, the frequency of impaired consciousness and the duration of hospitalization were higher in the IR group than in the ER group. Сonsciousness impairment was found to be an independent predictor of low efficacy of the rehabilitation (odds ratio 4.53; confidence interval 95 % 1.63–12.6; p < 0.05). Conclusions. RPI can be used as a tool for assessing the effectiveness of rehabilitation of patients after a critical illness. The duration of mechanical ventilation has a negative effect on the functional outcome at discharge from the intensive care unit. The initial level of consciousness can be a benchmark for predicting the effectiveness of rehabilitation. Further prospective studies are needed to identify predictors of the effectiveness of early rehabilitation.